{"name":"Opna Bio LLC","slug":"opna-bio-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE1QZVByRnpqSm9kZFJHeHpiNUlDbk1SMnpZWnZ6eUtHand5eU90dHZTZ2ZNWnVXUEVmd1o3cm1KQ3hZaVJfVEs0MU1ydjJ1dERRYWk3SXJkbElqM3lwbzlHR1FVa3hBXzhMelhkV21pbmtTMHdNQkVPWXp3ck4?oc=5","date":"2022-12-21","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker: Enlaza launches with $61M; Enveda brings in $68M - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker: Enlaza launches with $61M; Enveda brings in $68M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPaVU2dXZzb0RnaXd0MWNzSzJZZUJnYjVSR0ZIYUU1amNPVXBZTjJGOVdLMk1zc3pYYy1nc09jTkZhc0pwOUR5aS13UnZJLUtPSzRQbmhVMFl0QnBJblZpbkY1aFJSbDNISjBKWldrbG1Fck1aaUVGR0Z4NGYyN0tneGl0QXl3UkhTVHF3?oc=5","date":"2022-11-21","type":"pipeline","source":"BioPharma Dive","summary":"Cancer drugmaker Plexxikon gets new life as Opna Bio - BioPharma Dive","headline":"Cancer drugmaker Plexxikon gets new life as Opna Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwJBVV95cUxQQl9VX0RESHBfZmwwcGRyMGwwZW92dDJiTkpzYVJJMmdqTzFmd2xCdjBCX2Z6WXFhYjA0OVNxNk5WUHlWUldvTVJRWDNNQjMwTmZ5THhlZVJtSXd4RnV4SHJkeWRXMmJMVzBvb2kta2VTX1ZFajlMQmxNck93TmlGTkMydWJWSDFpR1VMWmo0enJGd29PcDR4bHh5Qjl3NENvb0xDeXNBVWt4Vlc0RnEzaU9WZGx4YTk4RFlxTmpnWU15aFRjTXRpdmQyY0tRZXNFN2tOdUlyZUsxb3VfcGp4b0xZWm93S1V4dk1SaC04UWFkX20ycEhmekdZVm1mZDZHVjYwTkNSVFU0Q0dYQUM3Z2dwUExVYzd0TkNtSm1VX1FSRlYzOTdxZm44ZVE2aWNnWmtaRmdSV3V4bnZmSXlB?oc=5","date":"2022-11-21","type":"pipeline","source":"businesswire.com","summary":"Opna Bio Launches with $38 Million Series A Financing to Advance Novel Oncology Discovery Program and Diversified Pipeline of Clinical and Preclinical Programs - businesswire.com","headline":"Opna Bio Launches with $38 Million Series A Financing to Advance Novel Oncology Discovery Program and Diversified Pipeli","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":7,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}